Future prospects for the prevention and cure of breast cancer

European Journal of Cancer

Volumn 36, Issue 9, 2000, Pages 1085-1088

  Fentiman, I S ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; FENRETINIDE; TAMOXIFEN;

BREAST CANCER; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; FEMALE; HORMONE SUBSTITUTION; HUMAN; MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SMOKING;

EID: 0034028128     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00088-5     Document Type: Article

References (37)

1. Moolgavkar S.H., Day N.E., Stevens R.G. Two-stage model for carcinogenesis. epidemiology of breast cancer in females Br. J. Cancer. 65:1980;559-569.
2. Cauley J.A., Lucas F.L., Kuller L.H.et al. Bone mineral density and risk of breast cancer in older women. The study of osteoporotic fractures. JAMA. 276:1996;1404-1408.
3. Zhang Y., Kiel D.P., Kreger B.E.et al. Bone mass and the risk of breast cancer among postmenopausal women. N. Engl. J. Med. 336:1997;611-617.
4. Breast cancer and hormonal contraceptives. collaborative re-analysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies Lancet. 347:1996;1713-1727.
5. Cummings S.B., Eckert S., Krueger K.A.et al. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. JAMA. 291:1999;2189-2197.
6. Roylance R., Gorman P., Harris W.et al. Comparative hybridisation of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res. 59:1999;1433-1436.
7. Harkin P.D., Bean J.M., Miklos D.et al. Induction of GADD45 and JNK/SAPK dependent apoptosis following inducible expression of BRCA1. Cell. 97:1999;575-586.
8. Osin P., Crook T., Powles T., Peto J., Gusterson B.A. Hormone status of in situ cancer in BRCA1 and BRCA2 mutation cases. Lancet. 351:1998;1487.
9. Powles T., Eeles R., Ashley S.et al. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet. 352:1998;98-101.
10. Zhang S., Hunter D.J., Forman M.R.et al. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. J. Natl. Cancer Inst. 91:1999;547-556.
11. Veronesi U., De Palo G., Marubini E.et al. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. J. Natl. Cancer Inst. 91:1999;1847-1856.
12. Tokunaga M., Land C.E., Yamamoto T.et al. Breast Cancer among atomic bomb survivors. Boice J.D., Fraumeni J.F. Radiation Carcinogenesis. Epidemiology and Biological Significance:1984;43-56 Raven Press, New York.
13. Modan B., Chetrit A., Alfandary E.et al. Increased risk of breast cancer after low-dose irradiation. Lancet. ii:1989;629-631.
14. Shore R.E., Hempelmann ?., Kowaluk E.et al. Breast neoplasms in women treated with x-rays for acute postpartum mastitis. J. Natl. Cancer Inst. 59:1977;913-922.
15. Mattsson A., Ruden B.-I., Hall P.et al. Radiation-induced breast cancer. long-term follow-up of radiation therapy for benign breast disease J. Natl. Cancer Inst. 85:1993;1679-1685.
16. Scott D., Barber J.B.P., Levine E.L., Burrill W., Roberts S.A. Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients. a test for predisposition? Br. J. Cancer. 77:1998;614-620.
17. 1-deoxy cytidine. Anti-Cancer Drugs. 10:1999;471-476.
18. Longnecker M.P. Alcoholic beverage consumption in relation to risk of breast cancer. Cancer Causes Control. 5:1994;73-82.
19. Boyle P. Does alcohol consumption increase the risk of breast cancer? Fentiman I.S. Challenges in Breast Cancer. 1999;35-41 Blackwell Science, Oxford.
20. MacMahon B.E., Trichopoulos D., Cole P.et al. Cigarette smoking and urinary estrogens. N. Engl. J. Med. 307:1982;1062-1065.
21. Khaw K.-T., Tazuke S., Barrett-Connor E. Cigarette smoking and levels of adrenal androgens in postmenopausal women. N. Engl. J. Med. 318:1988;1705-1709.
22. Kaufman D.W., Slone D., Rosenberg L.et al. Cigarette smoking and age at natural menopause. Am. J. Public Health. 70:1980;420-422.
23. Willet W., Stampfer M.J., Bain C.et al. Cigarette smoking, relative weight and menopause. Am. J. Epidemiol. 117:1983;651-658.
24. Weiss N.S., Farewell V.T., Szekely D.R.et al. Oestrogens and endometrial cancer. effect of other risk factors on the association Maturitas. 2:1980;185-190.
25. Daniell H.W. Osteoporosis of the slender smoker. Arch. Int. Med. 136:1976;298-304.
26. Calle E.E., Miracle-McMahill H.L., Thun M.J., Heath C.W. Cigarette smoking and risk of fatal breast cancer. Am. J. Epidemiol. 139:1994;1001-1007.
27. Fentiman I.S., Hyland D., Chaudary M.A., Gregory W.M. Prognosis of patients with breast cancers up to 1 cm in diameter. Eur. J. Cancer. 32A:1996;417-420.
28. Fisher B., Redmond C., Poisson R.et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N. Engl. J. Med. 320:1989;822-828.
29. Fentiman I.S. Detection and Treatment of Breast Cancer. 2nd edn. 1998;Martin Dunitz, London. 115-117.
30. Veronesi U., Luini A., Del Vecchio M.et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N. Engl. J. Med. 328:1993;1587-1591.
31. Krag D., Weaver D., Ashikaga T.et al. The sentinel node in breast cancer. A multicenter validation study. N. Engl. J. Med. 339:1998;941-946.
32. Hill A.D.K., Tran K.N., Akhurst T.et al. Lessons learnt from 5000 cases of lymphatic mapping for breast cancer. Ann. Surg. 229:1999;528-535.
33. Taylor-Papadimitriou J., Gendler S.J. Structure, biology and possible clinical applications of carcinoma associated mucins. Int. J. Oncol. 1:1992;9-16.
34. Fentiman I.S. Detection and Treatment of Breast Cancer. 2nd edn. 1998;Martin Dunitz, London. 83-93.
35. Fentiman I.S., Gregory W.M., Richards M.A. Effect of menstrual cycle phase on surgical treatment of breast cancer. Lancet. 343:1994;1544-1546.
36. Badwe R.A., Juvekar R.R. Timing of surgery during the menstrual cycle. Ann. Oncol. 5:1994;29-31.
37. Mohr P.E., Wang D.Y., Gregory W.M., Richards M.A., Fentiman I.S. Serum progesterone and prognosis in operable breast cancer. Br. J. Cancer. 73:1996;1552-1555.